Search Videos and More
News
Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.
News
ENDING THE RELIANCE ON BCG
The Phase III randomized trial compares Bacillus Calmette-Guerin (BCG) immunotherapy, the standard-of-care intravesical treatment for high grade non-muscle invasive bladder cancer, versus intravesical Docetaxel and Gemcitabine treatment in BCG naïve patients.
News
Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.
News
Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers from Fox Chase Cancer Center showed that using numerical cutoffs as opposed to radiologist-read CT scans to determine whether a mass was likely cancerous did not yield more accurate results.
News
Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that in men who have undergone surgery for prostate cancer, the function of artificial urinary sphincters for stress urinary incontinence was improved when radiation was used as an adjuvant therapy rather than as a salvage therapy.
News
Benign Prostatic Hyperplasia
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted leader in treating all types of urologic conditions.
News
Fox Chase-Temple Urologic Institute: The Next Generation of Urology Care
Our innovative partnership unites the expertise of distinguished institutions within one health system, allowing us to tackle the most challenging genitourinary malignancies as well as complex benign urologic conditions.
Course
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
Join us for this in-person educational program, presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced bladder, kidney, and prostate cancer from the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, and medical oncology.
News
Nothing is lost in translation for Russian-speaking patients with urologic cancers
“Even when I was four, I wanted to be a clinician; I’d sit with my grandpa, listen to his ailments, and write prescriptions for him in Russian,” says Elena Dreyzin, PA-C., an advanced practice provider in the Fox Chase Cancer Center Department of Urology.
News
Study Investigates Hypomethylation Immunotherapy Combination in Bladder Cancer
Why does immunotherapy work for some bladder cancer patients and fail for others?
News
Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses
A Fox Chase study ends up on the cover Journal of Urology cover by revealing a hidden danger in cystic renal masses.
Video
Aquablation: Changing the Surgical Landscape of BPH
Join Steve Sterious, MD FACS , Fox Chase-Temple Urologic Institute Provider, to discuss Aquablation and the changing surgical landscape of BPH.